title: Quetiapine XR: current status for the treatment of major depressive disorder.
authors.affiliation: Department of Psychiatry, Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, 2 Sosa-Dong, Wonmi-Gu, Pucheon, Kyounggi-Do 420-717, Republic of Korea. pae@catholic.ac.kr
authors.forename: Chi-Un
authors.initials: CU
authors.lastname: Pae
authors.forename: Manmohandeep Singh
authors.initials: MS
authors.lastname: Sohi
authors.forename: Ho-Jun
authors.initials: HJ
authors.lastname: Seo
authors.forename: Alessandro
authors.initials: A
authors.lastname: Serretti
authors.forename: Ashwin A
authors.initials: AA
authors.lastname: Patkar
authors.forename: David C
authors.initials: DC
authors.lastname: Steffens
authors.forename: Prakash S
authors.initials: PS
authors.lastname: Masand
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003865:Major Depressive Disorder / Q000188:drug therapy*; D003987:Dibenzothiazepines / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D000069348:Quetiapine Fumarate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate